Implementing Leadership Change, Gene One Scenario
University of Phoenix
March 26, 2012
Gene One is a biotechnology company on the verge of making some concrete decisions that would affect the future of the company and its employees. The root of Gene One's problems laid in a much less internalized issue. In this case, the creation and implementation of an IPO is causing Gene One to experience a host of issues which require a transformational approach to leadership in order to be resolved. Among the issues, Gene One faces communications issues, especially in regards to communication between executives and the employee base, as well as dilemmas in managing the group process and infrastructure. The purpose of this paper is to analyze the situation that Gene One is currently facing and identify the challenges facing the company and opportunities that might result from dealing with this problem.
Implementing Leadership Change, Gene One Scenario; Situation Background
Gene One entered the biotechnology industry in 1996 after the team discovered a groundbreaking gene technology that eradicated diseases in tomatoes and potatoes. This discovery pleased consumers, as they no longer needed to use chemicals in their products. It also pleased farmers, as they no longer needed to use pesticides when growing plants. Gene One became very successful and speedily grew into a $400 million company in a period of eight years. Over time, Wall Street began to have an interest in biotechnology and investors are beginning to build confidence in the industry. To keep up with the growing competition and ever changing global market, Gene One would have to keep up with its competition. In order to remain at the forefront of the competition, Gene One’s management team believed that they would have to go public within the next three years. However, in order to be successful in its endeavors, Gene One needs IPO...